Please login to the form below
ViroPharma
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.
Shire to file Vyvanse for binge-eating in Q3
The Viropharma deal - which closed last month - brings in an already-marketed drug for hereditary angioedema with sales running at around $100m a quarter last year. ... After a strong performance in 2013, and the completion of the ViroPharma acquisition,
Shire's ADHD drug fails in depression trial
This includes a restructure of its pipeline, as announced in November last year, as well as the £2bn purchase of rare disease specialist ViroPharma.
Pharma deals during November 2013
acquisitions. Following the rumours that had abounded over the last few months, the top of the table deal this month was the acquisition of ViroPharma, the orphan drugs company by Shire. ... In 2012 ViroPharma generated revenues of $428m, with Cinryze
Shire snaps up Viropharma to build $2bn rare disease unit
Gains access to Cinryze in expensive but 'strategically sound' deal. Shire has signed a deal to buy US company ViroPharma for around $4.2bn as it continues to build its portfolio ... The $50-per-share cash offer has been approved by both companies' board
Pharma deals during September 2013
Alexion, Biomarin and ViroPharma have all been under the spotlight this month as speculation shifts from large Pharma looking to get in on the action or an existing niche player making
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
- Why pharma must get smart in its approach to customer engagement
- BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- AstraZeneca's Enhertu receives FDA grant for priority review
- GSK appoint Tony Wood as chief scientific officer
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Cervical Cancer Prevention Month
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Almirall and IRB Barcelona announce new research collaboration
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Why pharma must get smart in its approach to customer engagement
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Assessing the value of interim analyses in clinical trials
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Almirall and IRB Barcelona announce new research collaboration
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...
Latest intelligence
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
- Hybrid working: Insights and tips for success
- Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...
